Cargando…
Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells
Invariant natural killer T (iNKT) cells act at the interface between lipid metabolism and immunity because of their restriction to lipid antigens presented on CD1d by antigen-presenting cells (APCs). How foreign lipid antigens are delivered to APCs remains elusive. Since lipoproteins routinely bind...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243825/ https://www.ncbi.nlm.nih.gov/pubmed/36976644 http://dx.doi.org/10.1172/jci.insight.158089 |
_version_ | 1785054507228463104 |
---|---|
author | Engelen, Suzanne E. Ververs, Francesca A. Markovska, Angela Lagerholm, B. Christoffer Kraaijenhof, Jordan M. Yousif, Laura I.E. Zurke, Yasemin-Xiomara Gulersonmez, Can M.C. Kooijman, Sander Goddard, Michael van Eijkeren, Robert J. Jervis, Peter J. Besra, Gurdyal S. Haitjema, Saskia Asselbergs, Folkert W. Kalkhoven, Eric Ploegh, Hidde L. Boes, Marianne Cerundolo, Vincenzo Hovingh, G.K. Salio, Mariolina Stigter, Edwin C.A. Rensen, Patrick C.N. Monaco, Claudia Schipper, Henk S. |
author_facet | Engelen, Suzanne E. Ververs, Francesca A. Markovska, Angela Lagerholm, B. Christoffer Kraaijenhof, Jordan M. Yousif, Laura I.E. Zurke, Yasemin-Xiomara Gulersonmez, Can M.C. Kooijman, Sander Goddard, Michael van Eijkeren, Robert J. Jervis, Peter J. Besra, Gurdyal S. Haitjema, Saskia Asselbergs, Folkert W. Kalkhoven, Eric Ploegh, Hidde L. Boes, Marianne Cerundolo, Vincenzo Hovingh, G.K. Salio, Mariolina Stigter, Edwin C.A. Rensen, Patrick C.N. Monaco, Claudia Schipper, Henk S. |
author_sort | Engelen, Suzanne E. |
collection | PubMed |
description | Invariant natural killer T (iNKT) cells act at the interface between lipid metabolism and immunity because of their restriction to lipid antigens presented on CD1d by antigen-presenting cells (APCs). How foreign lipid antigens are delivered to APCs remains elusive. Since lipoproteins routinely bind glycosylceramides structurally similar to lipid antigens, we hypothesized that circulating lipoproteins form complexes with foreign lipid antigens. In this study, we used 2-color fluorescence correlation spectroscopy to show, for the first time to our knowledge, stable complex formation of lipid antigens α-galactosylceramide (αGalCer), isoglobotrihexosylceramide, and OCH, a sphingosine-truncated analog of αGalCer, with VLDL and/or LDL in vitro and in vivo. We demonstrate LDL receptor–mediated (LDLR-mediated) uptake of lipoprotein-αGalCer complexes by APCs, leading to potent complex-mediated activation of iNKT cells in vitro and in vivo. Finally, LDLR-mutant PBMCs of patients with familial hypercholesterolemia showed impaired activation and proliferation of iNKT cells upon stimulation, underscoring the relevance of lipoproteins as a lipid antigen delivery system in humans. Taken together, circulating lipoproteins form complexes with lipid antigens to facilitate their transport and uptake by APCs, leading to enhanced iNKT cell activation. This study thereby reveals a potentially novel mechanism of lipid antigen delivery to APCs and provides further insight into the immunological capacities of circulating lipoproteins. |
format | Online Article Text |
id | pubmed-10243825 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Society for Clinical Investigation |
record_format | MEDLINE/PubMed |
spelling | pubmed-102438252023-06-07 Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells Engelen, Suzanne E. Ververs, Francesca A. Markovska, Angela Lagerholm, B. Christoffer Kraaijenhof, Jordan M. Yousif, Laura I.E. Zurke, Yasemin-Xiomara Gulersonmez, Can M.C. Kooijman, Sander Goddard, Michael van Eijkeren, Robert J. Jervis, Peter J. Besra, Gurdyal S. Haitjema, Saskia Asselbergs, Folkert W. Kalkhoven, Eric Ploegh, Hidde L. Boes, Marianne Cerundolo, Vincenzo Hovingh, G.K. Salio, Mariolina Stigter, Edwin C.A. Rensen, Patrick C.N. Monaco, Claudia Schipper, Henk S. JCI Insight Research Article Invariant natural killer T (iNKT) cells act at the interface between lipid metabolism and immunity because of their restriction to lipid antigens presented on CD1d by antigen-presenting cells (APCs). How foreign lipid antigens are delivered to APCs remains elusive. Since lipoproteins routinely bind glycosylceramides structurally similar to lipid antigens, we hypothesized that circulating lipoproteins form complexes with foreign lipid antigens. In this study, we used 2-color fluorescence correlation spectroscopy to show, for the first time to our knowledge, stable complex formation of lipid antigens α-galactosylceramide (αGalCer), isoglobotrihexosylceramide, and OCH, a sphingosine-truncated analog of αGalCer, with VLDL and/or LDL in vitro and in vivo. We demonstrate LDL receptor–mediated (LDLR-mediated) uptake of lipoprotein-αGalCer complexes by APCs, leading to potent complex-mediated activation of iNKT cells in vitro and in vivo. Finally, LDLR-mutant PBMCs of patients with familial hypercholesterolemia showed impaired activation and proliferation of iNKT cells upon stimulation, underscoring the relevance of lipoproteins as a lipid antigen delivery system in humans. Taken together, circulating lipoproteins form complexes with lipid antigens to facilitate their transport and uptake by APCs, leading to enhanced iNKT cell activation. This study thereby reveals a potentially novel mechanism of lipid antigen delivery to APCs and provides further insight into the immunological capacities of circulating lipoproteins. American Society for Clinical Investigation 2023-05-08 /pmc/articles/PMC10243825/ /pubmed/36976644 http://dx.doi.org/10.1172/jci.insight.158089 Text en © 2023 Engelen et al. https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Article Engelen, Suzanne E. Ververs, Francesca A. Markovska, Angela Lagerholm, B. Christoffer Kraaijenhof, Jordan M. Yousif, Laura I.E. Zurke, Yasemin-Xiomara Gulersonmez, Can M.C. Kooijman, Sander Goddard, Michael van Eijkeren, Robert J. Jervis, Peter J. Besra, Gurdyal S. Haitjema, Saskia Asselbergs, Folkert W. Kalkhoven, Eric Ploegh, Hidde L. Boes, Marianne Cerundolo, Vincenzo Hovingh, G.K. Salio, Mariolina Stigter, Edwin C.A. Rensen, Patrick C.N. Monaco, Claudia Schipper, Henk S. Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells |
title | Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells |
title_full | Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells |
title_fullStr | Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells |
title_full_unstemmed | Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells |
title_short | Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells |
title_sort | lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer t cells |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243825/ https://www.ncbi.nlm.nih.gov/pubmed/36976644 http://dx.doi.org/10.1172/jci.insight.158089 |
work_keys_str_mv | AT engelensuzannee lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT verversfrancescaa lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT markovskaangela lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT lagerholmbchristoffer lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT kraaijenhofjordanm lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT yousiflauraie lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT zurkeyaseminxiomara lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT gulersonmezcanmc lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT kooijmansander lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT goddardmichael lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT vaneijkerenrobertj lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT jervispeterj lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT besragurdyals lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT haitjemasaskia lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT asselbergsfolkertw lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT kalkhoveneric lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT ploeghhiddel lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT boesmarianne lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT cerundolovincenzo lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT hovinghgk lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT saliomariolina lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT stigteredwinca lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT rensenpatrickcn lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT monacoclaudia lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells AT schipperhenks lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells |